NKTR ▼ -0.1% - Nektar Therapeutics
$NKTR NKTR - Nektar Announces Three Oral Presentations for Rezpegaldesleukin at the European Academy of Dermatology & Venereology (EADV) Congress 2026
28-SEP-2026 08:02 AM ET
Share this post
More filings for $NKTR
NKTR ▲ +1.6% - Nektar TherapeuticsOct 12, 2026NKTR ▼ -17.7% - Nektar TherapeuticsOct 1, 2026NKTR ▼ -0.4% - Nektar TherapeuticsOct 1, 2026NKTR ▲ +1.7% - Nektar TherapeuticsSep 30, 2026NKTR - Nektar Therapeutics - SEC Filing Update (28-SEP-2026) | ThinkSabio - Stocks SimplifiedSep 28, 2026NKTR ▼ -4.0% - Nektar TherapeuticsSep 25, 2026
View full $NKTR filing history →💬 Comments
Loading comments…
Leave a comment